miR-21, miR-106b and miR-375 as novel potential biomarkers for laryngeal squamous cell carcinoma

Current Pharmaceutical Biotechnology

Volumn 15, Issue 5, 2014, Pages 503-508

  Guo, Junming ^a   Liu, Yang ^a   Wu, Yibo ^a   Xiao, Bingxiu ^a   Yu, Xing ^a   Deng, Hongxia ^a   Shen, Zhisen ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

Laryngeal squamous cell carcinoma; MicroRNAs; MiR 106b; MiR 21; MiR 375; Tumor markers

Indexed keywords

MICRORNA; MICRORNA 106B; MICRORNA 21; MICRORNA 375; TUMOR MARKER; UNCLASSIFIED DRUG; MIRN106 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; MIRN375 MICRORNA, HUMAN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; DYSPLASIA; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARYNX SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MIDDLE AGED; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; AGED; BLOOD; CARCINOMA, SQUAMOUS CELL; DISEASE COURSE; FEMALE; LARYNGEAL NEOPLASMS; MALE; PATHOLOGY;

AGED; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84907164054     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201015666140519110616     Document Type: Article

References (29)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer Stats., 2008. CA Cancer J. Clin., 2008, 58(2), 71-96.
2. Argiris, A.; Karamouzis, M. V.; Raben, D.; Ferris, R. L. Head and neck cancer. Lancet, 2008, 371(9625), 1695-1709.
3. Vergeer, M. R.; Doornaert, P. A.; Reitveld, D. H.; Leemans, C. R.; Slotman, B. J.; Langendijk, J. A. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a non randomized prospective study using a standardized follow-up program. Int. J. Radiat. Oncol. Biol. Phys., 2009, 74(1), 1-8.
4. Smith, R. B.; Snieze, J. C.; Weed, D. T.; Wax, M. K. Utilization of free tissue transfer in head and neck surgery. Otolaryngol. Head Neck Surg., 2007, 137(2), 182-191.
5. Micozkadioglu, D.; Unal, M.; Pata, Y. S.; Başţurk M.; Cinel, L. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma. Med. Sci. Monit., 2008, 14(6), CR299-304.
6. Bartel, DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 2004, 116(2), 281-297.
7. Lewis, B. P.; Shih, I. H.; Jones-Rhoades, M. W.; Bartel, D. P.; Burge, C. B. Prediction of mammalian microRNA targets. Cell, 2003, 115(7), 787-798.
8. Deng, H.; Guo, Y.; Song, H.; Xiao, B; Sun, W.; Liu, Z.; Yu, X.; Xia, T.; Cui, L.; Guo, J. MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer. Gene, 2013, 518(2), 351-359.
9. Guo, J.; Miao, Y.; Xiao, B.; Huan, R.; Jiang, Z.; Meng, D.; Wang, Y. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J. Gastroenterol. Hepatol., 2009, 24(4), 652-657.
10. Li, M.; Marin-Muller, C.; Bharad W. U.; Cho, W. K. H.; Yao, Q.; Chen, C. MicroRNAs: Control and loss of control in human physiology and disease. World J. Surg., 2009, 33(4), 667-684.
11. Krutovskikh, V. A.; Herceg, Z. Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers. Bioessays, 2010, 32(10), 894-904.
12. Cowland, J. B.; Hother, C.; Gronbaek, K. MicroRNAs and cancer. APMIS, 2007, 115(10), 1090-1106.
13. Calin, G. A.; Sevignani, C.; Dumitru, C. D.; Hyslop, T.; Noch, E.; Yendamuri, S.; Shimizu, M.; Rattan, S.; Bullrich, F.; Negrini, M.; Croce, C. M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U. S. A., 2004, 101(9), 2999-3004.
14. Pan, X.; Wang, Z. X.; Wang, R. MicroRNA-21: a novel therapeutic target in human cancer. Cancer Biol. Ther., 2011, 10(12), 1224-1232.
15. Poy, M. N.; Eliasson, L.; Krutzfeldt, J.; Kuwajima, S.; Ma, X.; Macdonald, P. E.; Pfeffer, S.; Tuschl, T.; Rajewsky, N.; Rorsman, P.; Stoffel, M. A pancreatic islet-specific microRNA regulates insulin secretion. Nature, 2004, 432(7014), 226-230.
16. Ivanovska, I.; Ball, A. S.; Diaz, R. L.; Magnus, J. F.; Kibukawa, M.; Schelter, J. M.; Kobayashi, S. V.; Lim, L.; Burchard, J.; Jackson, A. L. Linsley, P. S.; Clearym M. A. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell. Biol., 2008, 28(7), 2167-2174.
17. Wang, H.; Liu J.; Zong Y.; Xu Y.; Deng W.; Zhu H.; Liu Y.; Ma C.; Huang, L.; Zhang, L.; Qin, C. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer' s disease targets TGF-beta type II receptor. Brain Res., 2010, 1357, 166-174.
18. Childs, G.; Fazzari, M.; Kung, G.; Kawachi N.; Brandwein-Gensler, M.; McLemore M.; Chen, Q.; Burk, R. D.; Smith, R. V.; Prystowsky, M. B.; Belbin, T. J.; Schlecht, N. F. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am. J. Pathol., 2009, 174(3), 736-745.
19. Wong, T. S.; Liu, X. B.; Wong, B. Y.; Ng, R. W.; Yuen, A. P.; Wei, W. I. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin. Cancer Res., 2008, 14(9), 2588-2592.
20. Zhang, X.; Cairns, M.; Rose, B.; O'Brien, C.; Shannon, K.; Clark, J.; Gamble, J.; Tran, N. Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland. Int. J. Cancer, 2009, 124(12), 2855-2863.
21. Nohata N.; Hanazawa T.; Kikkawa N.; Mutallip M.; Sakurai D.; Fujimura L.; Kawakami, K.; Chiyomaru, T.; Yoshino, H.; Enokida, H.; Nakagawa, M.; Okamoto, Y.; Seki, N. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J. Hum. Genet., 2011, 56(8), 595-601.
22. Kinoshita, T.; Nohata, N.; Yoshino, H.; Hanazawa, T.; Kikkawa, N.; Fujimura, L.; Chiyomaru, T.; Kawakami, K.; Enokida, H.; Nakagawa, M.; Okamoto, Y.; Seki, N. Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma. Int. J. Oncol., 2012, 40(1), 185-193.
23. Zhou, H.; Xiao, B.; Zhou, F.; Deng, H.; Zhang, X.; Lou, Y.; Gong, Z.; Du, C.; Guo, J. MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients. Biomarkers, 2012, 17(2), 104-110.
24. Zheng, Y.; Cui, L.; Sun, W.; Zhou, H.; Yuan, X.; Huo, M.; Chen, J.; Lou, Y.; Guo, J. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients. Cancer Biomark., 2011-2012, 10(2), 71-77.
25. Xiao B.; Guo, J.; Miao, Y.; Jiang, Z.; Huan, R.; Zhang, Y.; Li, D.; Zhong, J. Detection of miR-106a in gastric carcinoma and its clinical significance. Clin. Chim. Acta., 2009, 400(1-2), 97-102.
26. Mao, Y.; Zhang, D. W.; Lin, H.; Xiong, L.; Liu, Y.; Li, Q. D.; Ma, J.; Cao, Q.; Chen, R. J.; Zhu, J.; Feng, Z. Q. Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma. J. Exp. Clin. Cancer Res., 2012, 31, 101.
27. Petrocca, F.; Visone, R.; Onelli, M. R.; Shah, M. H.; Nicoloso, M. S.; de Martino, I.; Iliopoulos, D.; Pilozzi, E.; Liu, C. G.; Negrini, M.; Cavazzini, L.; Volinia, S.; Alder, H.; Ruco, L. P.; Baldassarre, G.; Croce, C. M.; Vecchione, A. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell, 2008, 13(3), 272-286.
28. Ren, J.; Sun, Y.; Zhao, X.; Wang, X.; Feng, J.; Liu, M.; Zhu, D. Downregulation of miR-21 regulates MMP-2 expression and suppress migration of Laryngeal squamous cell carcinoma. Head Neck Oncol., 2012, 4(2), 65.
29. Ren, J.; Zhu, D.; Liu, M.; Sun, Y.; Tian, L. Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma. Eur J Cancer, 2010, 46(18), 3409-3416.